Insilico Medicine earns second consecutive Prix Galien USA “Best Start-Up” Nomination
Insilico Medicine included in MSCI Global Small Cap Indexes, gaining capital market endorsement in core strengths
Insilico Medicine introduces biological age into virtual cell research: launches virtual aging cell webpage and previews multi-agent driven VAC generation platform - EurekAlert!
Insilico Medicine nominates ISM0900, a potent, AI-driven, oral Lp(a) inhibitor, as PCC for management of cardiovascular risks - EurekAlert!
Science Signaling | Insilico Medicine contributes to research using AI to reveal NDRG1-associated DNA repair mechanisms and potential synthetic lethal effects in colorectal cancer - EurekAlert!
AI-empowered pipeline-in-a-drug option: Insilico Medicine nominates ISM9077, potential first-in-class target Y inhibitor, as preclinical candidate (PCC) for ocular diseases, inflammatory disorders and aging - EurekAlert!
Insilico Medicine receives NMPA IND clearance for innovative oral candidate ISM8969/HT-001, the brain-penetrant NLRP3 inhibitor co-developed with Hygtia Therapeutics - EurekAlert!
Weely Conference: Insilico Medicine at Ai4 2026: Dr. Alex Zhavoronkov to deliver two keynote sessions on AI drug discovery and anti-aging - EurekAlert!
Insilico Medicine announces oral presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in mesothelioma and advanced solid tumors - EurekAlert!
Weekly Events | Insilico Medicine executives at CPIC: navigating the dual breakthrough of tech innovation and clinical validation in AI drug discovery - EurekAlert!
Insilico Medicine and Bora Pharmaceuticals announce strategic alliance for AI-driven drug discovery and development - EurekAlert!
Insilico Medicine and Eli Lilly to anchor 13th Aging Research & Drug Discovery (ARDD) meeting at the David Rubenstein Treehouse at Harvard University - EurekAlert!
Spotlighting longevity and AI drug discovery: Insilico Medicine to showcase at BIO Asia-Taiwan 2026 - EurekAlert!
Insilico Medicine releases positive profit alert for the first half of 2026 - EurekAlert!
Pharma.AI Q2 2026 Summer Webinar: A Deep Dive into Insilico Medicine’s Latest Platform Upgrades - EurekAlert!
Insilico Medicine shines at International Executive Summit, sharing the journey from tech innovation to clinical validation in AI drug discovery - EurekAlert!
Insilico Medicine announces collaboration with Takeda to advance strategic AI drug discovery - EurekAlert!
Insilico Medicine caps monumental week at BIO 2026: Secures landmark $2.5B partnership and dominates thought leadership - EurekAlert!
Insilico Medicine caps monumental week at BIO 2026: Secures landmark $2.5B partnership and dominates thought leadership - EurekAlert!
Weekly Conferences | From San Diego to Shanghai: Insilico Medicine showcases new advances in AI-driven drug discovery - EurekAlert!
